Macronutrient supplements may reduce breast cancer risk: how, when and which?

Chemotherapy in early breast cancer: when, how and which one?

The efficacy of chemotherapy depends on the level of risk of the individual patient. Because of this, careful estimation of the risk level is mandatory. In addition to well-established clinicopathological factors, validated gene expression signatures might be useful in selected patients if all other criteria are inconclusive for therapeutic decision-making. If indicated, chemotherapy can be use...

Which Strategies Reduce Breast Cancer Mortality Most?

BACKGROUND US breast cancer mortality is declining, but thousands of women still die each year. METHODS Two established simulation models examine 6 strategies that include increased screening and/or treatment or elimination of obesity versus continuation of current patterns. The models use common national data on incidence and obesity prevalence, competing causes of death, mammography charact...

Aromatase inhibitors may reduce endometrial cancer risk.

Use of aromatase inhibitors, which are known to reduce endogenous oestrogen levels, as adjuvant therapy had a lower risk of endometrial cancer, compared with that of patients who were treated with tamoxifen, results of a new study show. In this study, Rowan Chleblowski and colleagues (Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, CA, USA) examined the rec...

Breast Cancer: Risk Factors, Diagnosis and Management

ABSTRACT           Breast cancer remains the most common cancer of women and one of the most common causes of cancer-related deaths worldwide. In spite of major advances in breast cancer diagnosis and treatment, the incidence of breast cancer remains high and the treatment of metastatic breast cancer remains challenging. This review presents an over...

Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer.